Topics
Gliomas | Treatment | Targeted therapy | Infigratinib
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Infigratinib
Chen Y, Ma J, Gao Q, Gai Y, Sun Y, Wang M.
Larotrectinib
versus infigratinib for adult patients with both glioma and
tyrosine kinase alterations after failure of initial therapies:
Efficacy and safety analysis.
Clinics
(Sao Paulo). 2024 Feb 7;79:100329. doi:
10.1016/j.clinsp.2024.100329. PMID:
38330791. Observational
study.
ˍ